Growth of Elderly People is Responsible for the Self-Monitoring Blood Glucose Devices Market Expansion

The self-monitoring blood glucose devices market made USD 25.3 billion in 2023, and it will advance at a rate of 9.7% by the end of this decade to touch USD 48.2 billion by 2030.

The industry growth has a lot to do with the growing occurrence of diabetes, increasing populace of elderly people, tech progressions, booming consciousness of diabetes care, increasing count of obese people, and favorable health insurance and repayment scenario.

Self-sugar-measuring gadgets are used in the monitoring of type 1 and 2 diabetes, and a few other ailments. Amongst all applications, type 2 diabetes had the largest share, of more than 50%, in 2023.

Type 2 diabetes is a common lifestyle ailment that can cause key health problems, chiefly in the blood vessels of the eyes, kidneys, and the nerves. Some of the key problems of the ailment are diabetic retinopathy and diabetic nephropathy.

Tech progressions in SMBG gadgets is a key trend in the self-monitoring blood glucose devices market, as the use of new-age devices decreases the time taken to test sugar levels as opposed to the traditional approaches used in labs. Furthermore, most of these devices are moveable and suitable to carry.

The unparalleled aging rate observed in the worldwide populace is a key contributor to the diabetes occurrence, and elderly people represent one of the fastest-growing segments of the diabetic populace. In emerging nations, the increase in the occurrence of chronic non-infectious illnesses, such as diabetes, cancer, and heart ailment, hints at alterations in the lifestyles and diets, along with aging.

Nearly 80% of the world’s older people will be living in emerging regions by 2050. Also, the number of people aged 60 years or more in emerging regions will surge to 1.7 billion by 2050.

It is because of the increasing prevalence of diabetes all over the world, the requirement for self-monitoring blood glucose devices is on the rise3. This will continue in the years to come as well.

Read More

Orthopedic Category Led the Medical X-Ray Film Processor Market

The medical X-ray film processor market will reach USD 1,238.5 million revenue by 2030, progressing at a rate of 3.2% by the end of this decade, rising considerably from USD 998.7 million in 2023. This is because of the increasing occurrence of cancer, orthopedic diseases, dental issues, and cardiac ailments, accompanied by the growing count of X-ray imaging procedures, mounting consciousness of early diagnosis, and growing healthcare spending.

To learn more about this report: https://bit.ly/3RYrabS

The fully automatic film processor led the industry with a share of 60%, in 2023, as a result of the high image eminence of these variants. Furthermore, as they need less processing time than the manual ones, additional films can be handled in a given period.

Also, the automated variant decreases the inconsistency in the film quality improved compared to manually processed films, since the solution temperature, processing time, and chemical replenishment are regulated automatically.

The orthopedic category had the largest medical X-ray film processor market share, on the basis of application. This is because of the widespread use of X-rays in numerous orthopedic practices to identify and monitor joint and bone conditions, for example dislocation, fractures, and arthritis. X-ray film processors are put to use for developing X-ray films required to produce diagnostic images, which aid healthcare specialists sense the condition and treat the patient consequently.

Therefore, the growing count of orthopedic cases will power the growth of the industry. For example, in the U.S., about 7 million orthopedic surgeries were done in 2021, which reflects a considerable volume of X-ray scans for diagnosis.

Stalwarts of the market have grown over the past by adding novel products to their portfolios and snowballing the occurrence of attainments and partnerships. In addition, these strategic associations and product introductions bring about a competitive edge.

For example, in March 2021, Fujifilm Corporation publicized that it has entered an arrangement with Hitachi Ltd. to obtain Hitachi’s diagnostic imaging business, so as to increase its healthcare business.

With the surge in the occurrence of chronic ailments and the increase in the elderly populace, the requirement for X-ray imaging procedures has increased in North America. Also, the industry is powered by the incidence of more than a few key players, obtainability of tech advanced products, and increasing consciousness of the early analysis of ailments. Furthermore, in the U.S., the count of hospitals is growing, with about 8,000 of these functioning as of 2023.

It is because of the rising incidence of cancer all over thew world, and increasing awareness of early diagnosis, the demand for medical X-ray film processor is on the rise. This trend will continue in the years to come as well.

Read More

Software had a Considerable Share in the Patient Referral Management Software Industry

The size of the patient referral management software market was USD 9,598.3 million in 2023, and it will power at a rate of 17.9% by the end of this decade, to touch USD 30,221.2 million by 2030.

To learn more about this report: https://bit.ly/4aHv5kv

The increasing elderly populace across numerous nations, government initiatives to boost healthcare systems to accept IT solutions, and incessant tech expansions are some of the major reasons that can be credited for the growth of the industry.

Moreover, precision in scheduling actions, competence in data management, streamlining of everyday processes, and development in the access to medical amenities are some of the recompences of this kind of software that would let the industry to uphold momentum.

More than a few ailments are common in old age. An effective referral system can support in upholding the needed degree of communication and coordination amongst the numerous levels of the healthcare system, for example secondary-care hospitals, main-care or local hospitals, and tertiary-care facilities.

The patient referral management software market share of the cloud-based category will be the larger in the years to come. It can be credited to the rising recognition of cloud-based solutions because of their negligeable capital spending for data security, hardware setup, deterrence of the loss of info, and enhanced scalability of the storing capacity. Health records and further critical data can be managed and stored online more easily by using cloud-based solutions.

Eventually, cloud deployment offers improved flexibility and cost-efficiency as opposed to on-premises disposition. Applications, software, and tools can be effortlessly combined with the cloud system, and therefore, the requirement for cloud-based solutions will be on the rise in the future.

It is because of the growing elderly population all over the world, the requirement for patient referral management software is on the rise. This trend will continue to grow in the years to come as well.

Read More

Hospitals are the Foremost Users of the Healthcare Equipment Rental

The total value of the healthcare equipment rental market was USD 59.1 billion in 2023, and it will power at a rate of 5.7% by the end of this decade, to touch USD 86.8 billion by 2030.

To learn more about this report: https://bit.ly/3vke2F9

The growth has a lot to do with the growing requirement for medical instruments and rising count of hospitals and clinics providing advanced care. Furthermore, the high rate of medical equipment and the tax reimbursements on renting it are contributing to the growth of the industry. The introduction of tech cutting-edge products, for example sling lifts, will power the healthcare equipment leasing actions further.

Durable medical equipment held a key share, of 35%, as it supports more and more use. The growing count of disabled and elderly individuals will power the requirement for mobility and other sorts of assistive instruments, which will contribute to the development of this category.

The homecare category will grow at a substantial rate in the years to come, credited to the thriving prevalence of numerous ailments, for example diabetes, which needs therapeutic devices, such as insulin pumps.

The increasing need for home healthcare devices and elderly care centers is among the most-significant drivers for the healthcare equipment rental market in this category. The category’s development is bolstered by the rising populace of the aging, which is particularly susceptible to diabetes and cardiac ailments.

North America is the leader of the pack, with USD 29.5 billion, in 2023. This is because of the high requirement for the cutting-edge products and the existence of numerous leasing service providers. Furthermore, the increasing device cost powers the spending on the acquisition of the state-of-the-art therapeutic apparatus, which can be resolved by renting the equipment.

Due to the growing demand for medical instruments all over the world, the demand for healthcare equipment rental is on the rise. This trend will continue in the years to come as well.

Read More

Accelerometer Medical Sensors Industry Will Advance at a 14.4% CAGR

The accelerometer medical sensors market was USD 4,111.5 million in 2023, which will rise to USD 10,442.9 million, advancing at a 14.4% compound annual growth rate, by 2030.

To learn more about this report: https://bit.ly/3tzwyc6

This growth is mainly driven by the rising need for nonstop monitoring of health; physiological sensors miniaturization; and enhanced functions, cost-effectiveness, and ease of operation of these devices.

Furthermore, this growth is also assisted by the surging populace with high disposable salaries, which suggests they can easily spend money on developed technologies.

The wearables category, on the basis of products, is the major contributor to the industry. This can be because it is employed for measuring different factors of health like blood pressure, heart rate, and carbon dioxide level. The measurement of such factors assists healthcare professionals as well as researchers in gaining responses and providing greater treatment.

The hospitals & clinics category, on the basis of end user, is the major contributor to the industry. This can be because of the speedy acceptance of developed technologies, easy treatment availability and affordability, the existence of experienced specialists in these healthcare facilities, and the large patient pool.

Furthermore, the existence of numerous hospitals and the rising healthcare spending in both developing and developed nations like China, the U.S., and the U.K., and various chronic illness-associated surgeries are conducted in hospitals, which boosts the expansion of this category.

The chronic illness & risk monitoring category, on the basis of application, is leading the accelerometer medical sensors market. This is primarily because of the rising occurrence of cancer, cardiovascular illnesses, and other illnesses. The key causes of these illnesses comprise smoking and tobacco consumption, unhealthy dietary habits, and obesity. 

Moreover, the wellness monitoring category will propel at the fastest compound annual growth rate in the years to come. This is primarily because of the monitoring or tracking of health care parameters in a digital setting using sensor-based devices, which assists in monitoring movement as well as intensity.

North America is the largest contributor to the industry, and it is likely to remain the largest, generating USD 1.8 billion in 2030. This can be mainly because of the well-established healthcare system, coupled with the high disposable salary in this continent.

APAC is likely to be a significant contributor to the industry in 2030. This will be mainly attributed to the increasing unhealthy lifestyle among people, the surging aging populace, the rising incidence of cardiovascular illnesses, and the growing acceptance of developed technologies.

It is because of the rise in awareness about health and fitness, the accelerometer medical sensors industry will continue to grow significantly in the years to come.

Read More

North America Is Dominating Pyrogen Test Market

Revenue of USD 1,406.4 million was generated in the global pyrogen test market for 2023, which is expected to grow at a compound annual growth rate of 7.3% over the period from 2024 to 2030 and reach USD 2,284.2 million. This growth of the market can be credited to the increasing acceptance of pyrogen testing within the biopharmaceutical sector.

To learn more about this report: https://bit.ly/3viQeS0

Furthermore, the rising development in the biotechnology and pharmaceutical industries along with the increasing count of new biologics research and introductions is projected to fuel the demand for these testing for making safe and better drugs.

Pyrogen testing is a vital step for each medication and therapeutics to make it safer and more effective. Surge in the count of cancer cases and hereditary illnesses, modified treatments attained benefits in the treatment of these diseases.

Tailored medicine has the benefit that it uses people’s hereditary profiles to aid in decision-making for the prevention, diagnosis, and treatment of illnesses. Therefore, patients and businesses are quickly accepting modified drugs. Furthermore, modified treatment-based methods to clinical and genomic features are becoming more popular among patients with cancer and immunologic sicknesses. Hence, the increasing need for modified drugs is one of the key reasons propelling the demand for pyrogen testing solutions.

In the North American region, the U.S. dominates the industry. This is mainly because of the existence of advanced healthcare infrastructure, augmented concentration on new drug growth, and the presence of key biotechnology and biopharmaceutical companies, like Pfizer Inc. and F. Hoffmann-La Roche AG, in the country.

Furthermore, Canada is also generating substantial revenue for the North American industry. This can be credited to the rising pharmaceutical and biotechnology sector, the rising awareness regarding the safety of medications, and the growing R&D activities in the country.

Read More

AI in Medical Diagnostics Market is Led by North America

The size of the AI in medical diagnostics market was 1,297.6 million in 2023, and it will power at a rate of 23.1% by the end of this decade, to touch USD 5,541.7 million by 2030. 

This has a lot to do with the growing initiatives of the government for the acceptance of AI-based tech, the increasing usage of AI solutions by radiologists to reduce workload, the obtainability of funds to initiate AI-based startups, the arrival of big data, and the growing count of cross-industry partnerships & alliances.

Software was the leading component category, with about USD 0.5 billion in 2023, and it will also be like this in the years to come. This is because of the growing need for AI solutions based on software in the medical diagnostics industry for delivering precise outcomes in a short time and the growing count of IT firms delivering the same. 

Apart from that, the increasing expansion of novel software and new AI algorithms, and the mounting applications of AI-based software in more than a few fields for example radiology, cardiology, ophthalmology, neurology, and gynecology, amongst others are fostering the industry growth.

The in-vivo diagnostic category had a major revenue share, of 60%, in 2023, because of the growing occurrence of infectious along with chronic ailments, and maternity problems throughout childbirth. 

Amongst the in-vivo diagnostic applications, the neurology category has the largest share, because of the compensations of AI in diagnosing numerous neurological conditions for example cancers and brain tumors. Furthermore, AI aids radiologists in interpreting medical images for fast and precise diagnosis, minimalizing noise in medical images, and producing superior images with lesser radiation doses.

In the future, the ultrasound category will have a considerable share of the AI in medical diagnostics market. This is due to the mounting demand for ultrasound imaging test processes to identify more than a few ailments and conditions, together with the high level of precision in ultrasound, which is attained through AI.

North America is the leader of the industry, with a share of 45% in 2023. This is because of the high research and development investments, the increasing acceptance of tech cutting-edge solutions, and the existence of global players and their efforts to crop up with innovative medical diagnostics techs, in the region.

It is because of the rising use of AI solutions by radiologists to reduce workloads all over the world, the demand for AI in medical diagnostics solutions is on the rise. This trend will continue in the years to come as well.

Read More

Semiconductors Chemicals Market Will Reach USD 28.3 Billion by 2030

The global market size of semiconductor chemicals was estimated to be USD 12.5 billion. billion by 2023, and it is expected to grow at a compound annual growth rate of by 2030, the rate of 12.5% over 2024 to 2030 should reach USD 28.3 billion.

This growth of the market can be credited to the increasing usage of electronic devices, such as smartphones, laptops, and IoT gadgets, which has, ultimately, propelled the making of semiconductors. This has generated a high demand for chemicals that are utilized in wafer fabrication procedures. Furthermore, the progressing semiconductor technologies, like complex designs, and the evolution to smaller nodes require the growth of new chemicals, in order to fulfill the needs for efficiency, miniaturization, and performance.

The APAC region holds a substantial position in the semiconductor chemicals industry, and the region is projected to reach a value of over USD 6.0 billion by 2030. This can be credited to the increasing automotive sector and the increasing output of semiconductors. Along with the growing semiconductor production, the increasing R&D in this area is a substantial driver. The industry is also rising due to the robust government aid for digitization and the existence of key companies. In APAC, China grips the foremost position, credited to the fast acceptance of progressive technologies.

The global semiconductor market is witnessing a major trend, driving substantial growth in the semiconductor chemicals market. This growth is attributed to the pivotal role of semiconductor chemicals in powering electronic devices like tablets, smartphones, and laptops.

The increasing demand for semiconductor chemicals is driven by the widespread adoption of modern technologies across various industries. These chemicals play a crucial role in manufacturing and advancing semiconductor components used in diverse sectors such as aerospace, automotive, and general manufacturing.

The conductivity and efficiency of semiconductors are determined by the dopants incorporated during production. Proper functioning of these devices requires processes like etching, cleaning, doping, polishing, servicing, and regular maintenance. There is a continuous effort to improve efficiency and functionality by employing new materials in wafer fabrication, with a significant emphasis on sustainability. These advancements align with the growing use of renewable energy, electric vehicles, the Internet of Things (IoT), and other environmentally friendly approaches to life.

The market for semiconductor chemicals is driven by the adoption of advanced digital technologies across industries.

Read More

Healthcare Analytical Testing Services Market To Grow Fastest in the APAC

The size of the healthcare analytical testing services market was USD 7,240.1 million in 2023, and it will power at a compound annual growth rate of 11.5% by the end of this decade, to touch  a value of USD 15,390.5 million by 2030. 

This growth has a lot to do with the growing count of subcontracting actions of analytical testing services by some pharma companies. Furthermore, the rising count of clinical trials that include analytical testing, the growing requirement for drugs and therapeutics, and the increasing importance on biosimilars are other factors pushing the growth of the industry.

The bioanalytical testing services category held a major revenue share, of around 25%, in 2023. This is due to the accessibility of extensive bioanalytical testing services for a wider range of drug types, such as small molecules, biologics, and vaccines, and several drug manufacturers are constantly working to produce more reliable healthcare analytical procedures that are accurate and efficient.

Furthermore, the higher requirement for the newest bioanalytical testing services is observed by contract producers. Apart from that, large firms are reviving their pipelines by investing in research and development departments, and because of the growing difficulty of these testing services, companies are compliant with the norms and rules levied on them. 

Therefore, these factors are powering the requirement for healthcare analytical testing services. Likewise, the molecule bioanalytical requirement is on the rise, owing to the growing investments in amino acid production-based molecules and biological drugs.

Furthermore, the use of cell-based assays in bioanalytical testing services is resulting in high requirements for this kind of service. These cell-based assays are widely employed in high-throughput screening due to their competence in offering valuable in-vivo biological info that thus bustles the drug discovery procedure.

North America is the leader of the healthcare analytical testing services market, with manufacturers providing testing instruments along with high-end pharma materials, tech progressions, and collaborations amongst industry players to advance cutting-edge healthcare solutions.

APAC will power at the fastest rate of 12% in the years to come. This growth has a lot to do with the increasing investments by foreign corporations for the development of cutting-edge facilities and associations to increase the reach of their products and services to diverse locations, and enhancements done by governing bodies for varying standards of assessment to line up with the international standards in the region.

It is because of the acceptance of novel techniques all over the world, that the demand for healthcare analytical testing services is on the rise. This trend will continue in the years to come as well.

Read More

Imaging Chemicals Market Will Touch USD 47.0 Billion in 2030

The imaging chemicals market was USD 31.7 billion in 2023, which will touch USD 47.0 billion, with a 5.8% compound annual growth rate, by 2030.

The growth of this industry is primarily because of the different uses of these chemicals like packaging, printing, textiles, and medical diagnostics.

The growing occurrence of brain disorders, cancer, and various other illnesses boosts the need for diagnostic imaging tests, including magnetic resonance imaging, computed tomography, and X-rays. 

Furthermore, the growing acceptance of digital printing, as it is quicker and more effective compared to traditional processes, is further boosting this category expansion. The acceptance of digital printing is also rising because of the shifting customer demands.

The printing & packaging category, based on application, was the largest contributor to the imaging chemicals market. This is because of the growing need for printing and packaging across the globe. Therefore, the surging need for the different chemicals utilized for this purpose makes the industry competitive.

Therefore, the growing occurrence of chronic illnesses that need radiological studies will boost this industry during this decade.

North America was the largest contributor to the industry in 2023, with a 45% share. This can be ascribed to the existence of highly developed healthcare infrastructure in this continent, as well as the increasing customer spending on healthcare. 

In addition, the U.S. was a significant contributor to the North American industry. This is because of the use of developed healthcare technologies in this country, coupled with the rising research activities in the continent.

With the rising application of these chemicals across different sectors, the imaging chemicals industry will continuously advance in the years to come.

Read More

Patient Registry Software Market Will Reach USD 5,638.3 Million By 2030

The value of the patient registry software market stood at USD 2,091.0 million in 2023, and this number is projected to reach USD 5,638.3 million by 2030, advancing at a CAGR of 15.3% during the projection period. The need for integrated registries is being boosted by the increasing occurrence of chronic illnesses, like diabetes, cancer, and cardiovascular illnesses,and the growing acceptance of electronic health records.

In 2023, the disease registry category generated the highest revenue, of USD 1.1 billion. Patients going through certain illnesses are registered in these registries. The leading share of this category is because of the elderly populace, surge in chronic and novel & uncommon illness occurrence, development in the understanding of the position of registries in health management, and extensive acceptance of EHRs.

 Illness registries are becoming more helpful as new ones provide historically comparable information and permit long-term assessment. Their acceptance is also being boosted by the increasing government efforts to make and handle patient health records at lesser prices and growing awareness of how to gather and use patients’ health data.

An electronic health record is a digitally stored, systematized collection of health information for patients and the general population. The sharing of such data is possible, by means of other information systems and exchanges including those that are network-connected or enterprise-wide IT systems, between different healthcare facilities. 

Electronic health records might comprise a range of information, like demographics, billing information, prescription, medical history and allergy data, radiological pictures, immunization status, laboratory test results, and data on vital signs.

Because of its user-friendly tools and sophisticated features, standalone software has a larger industry share. Standalone software covers rare diseases, cancer, cardiovascular disease, diabetes, and patient details. As a result, the data is accessible and extremely comprehensive.

During the projection period, the integrated category is projected to experience quicker expansion. An integrated system is an assembly of software utilized to screen the places impacted by an illness and measure the efficiency of clinical involvement. It also aids in learning more regarding illness occurrence and the effectiveness of treatment choices. Several modules of integrated software offer an extensive variety of functionalities not typically seen in standalone applications.

A defined group of people's clinical health results are advanced by better care management and patient participation, which are backed by appropriate financial and care models. This procedure is known as populace health management.

North America is the largest contributor to the industry in 2023. This can be ascribed to the increasing target population, growing need for population-based registries, and surging prevalence of diseases in this region. Moreover, the increasing government activities to promote the acceptance of these solutions make the continent a major user of these programs.

Read More

Hypervisor Market was Led by the APAC Region

 The revenue of the automotive hypervisor market was USD 218.1 million in 2023, and it will reach USD 1,168.3 million by 2030, proceeding at a rate of 27.2% by the end of this decade. 

The main factors powering the growth of the industry are the increasing requirement for autonomous and connected vehicles, growing pace of progression in EVs, surging consciousness of passenger and safety of the vehicles, and developing user interfaces and infotainment.

On the basis of the automation level, the semi-autonomous category will have a larger share in the years to come. This will be for the reason that consumers are becoming interested in automobiles with cutting-edge driver-assistance features and seeking a balance amid convenience, safety, and the driving experience. 

Also, the growing telecom & IT infra, improving living standards, and increasing count of upper-class individuals are driving the growth of this category.

Furthermore, they have powerful engines and cutting-edge suspension systems, which require sophisticated software management. The hypervisor tech helps enhance the coordination amid numerous systems in luxury cars, to offer optimal performance.

Also, because of the existence of top automotive companies, for example Mercedes-Benz, Audi, and BMW, in the U.S. and Germany, this category will grow in these nations. Moreover, the increasing sales of luxury vehicles and the growing requirement for automated systems in these vehicles powers the market growth in the nation.

APAC led the hypervisor market, with a share of 55%, in 2023, and it will grow at the fastest rate. The rising per capita income in developing economies, for example India and China, has augmented the customer’s purchasing power, which will power the passenger car sales. 

Along with this this, the region has some of the world’s largest automotive manufacturers and component suppliers. This manufacturing strength lets for the quick acceptance of new tech in numerous vehicle brands and models. 

Also, the easy obtainability of labor at a low cost for vehicle’s mass production has brought about the formation of several manufacturing plants. Furthermore, the advent of local players with state-of-the-art models in emerging markets will power the industry growth. 

Read More

BEV category is the Leader of the Electric Powertrain Market

The electric powertrain market was USD 95.9 billion in 2023, and it will propel at a rate of 13.1% by the end of this decade, to reach a total value of USD 226.3 billion by 2030. The growing requirement for e-vehicles and the numerous government initiatives taken at the global level for GHG emission reduction are a few key forces powering the expansion of the industry.

The battery category, under the component segment, is likely to dominate the market and grow at a CAGR of 13.0% during the projection period. 

The battery is among the major components of e-vehicles and has a substantial weightage. Therefore, the increase in the requirement for EVs will power the generation of revenue from traction battery sales. 

Moreover, there are different batteries for EVs, for instance, nickel–metal hydride batteries, lead–acid batteries, lithium-ion batteries, and ultracapacitors, amongst which lithium-ion batteries are increasingly common. Upon driving, this discharge, and then, the automobile is plugged into a charging station. Vehicle manufacturers offer a battery warranty, with regards to miles or years. 

Moreover, North American companies are investing to introduce plants for cathode manufacturing, to guarantee a smooth supply chain for EV batteries.

Numerous legislations are there at a global level with regards to environmental safety. For example, in India, the norms of Corporate Average Fuel Efficiency mandate that for each auto manufacturer, carbon emissions should be lower than 130 g/km till 2022 and less than 113 g/km after 2022.

The BEV category led the electric powertrain market, and it will advance at a rate of 13.2% in the future. This has a lot to do with the fact that these variants bring about a considerable reduction in emissions of carbon and, hence, obtain the sturdiest policy and financial assistance from the governments. 

There are no engines in BEVs and, the power on rechargeable batteries, thus producing negligible-to-no quantities of GHG and other air pollutants. Therefore, they are an efficient and clean means of transport with the added benefit of negligible-to-no noise pollution.

To ensure substantial infiltration of these environment-friendly automobiles, governments are taking more than a few initiatives, for example spreading consciousness, offering tax benefits, and advancing the charging infra. This is done so that users can avoid any sort of issue due to inaccessibility of charging stations, and depleted battery while traveling long distances.

It is because of the increasing requirement for EVs and associated infra of the world, that the demand for electric powertrains is on the rise. This trend will continue to grow in the years to come as well.

Read More

Medical Equipment Maintenance Market is Driven by Developments in Medical Devices

The medical equipment maintenance market was USD 48.9 billion in 2023, and it will touch USD 98.9 billion, powering at a 10.7% compound annual growth rate, by 2030.

To learn more about this report: 

The growth in this industry is because of the enhancements in medical devices, increasing consciousness regarding preventive maintenance, and strict regulatory environments all over the world.

The imaging category, on the basis of type, will lead the industry throughout this decade. This can be mainly because of the extensive utilization of imaging equipment for different medical conditions, such as neurological disorders and cancer.

The preventive and predictive category, on the basis of service type, is likely to propel at the fastest compound annual growth rate, in the years to come. This can be mainly because of the extensive range of services provided by service providers in the category, which produces huge expense savings for public- and private-sector establishments.

North America was the largest contributor to the industry in 2023, and it will remain leading in the years to come. This can be mainly because of the surging aging populace, increasing burden of ailment, growing acceptance of medical imaging systems, and rising count of hospitals.

Asia-Pacific is likely to observe the highest compound annual growth rate in the years to come. The key factors boosting this progression would be the surging incidence of chronic illnesses that need medical devices for early diagnosis and the rising count of diagnostic tests conducted in this region.

It is because of the continuous progression of medical devices, the medical equipment maintenance industry will continue to progress in the years to come.

Read More

Transplant Diagnostics Market was Led by the Molecular Assays Category

The transplant diagnostics market was valued at USD 4,686.7 million in 2023, and it will grow at a rate of 7.5% by the end of this decade, to touch USD 7,713.5 million by 2030.

To learn more about this report: https://bit.ly/3vek5es

This is attributable to the growing requirement for organ replacement procedures, the growing requirement for diagnostic procedures before organ replacement, and the powering occurrence of communicable diseases. 

Also, the number of people with final-stage organ failure is on the rise, and because of the development in organ transplantation procedures, a high number of patients can now access these surgeries.

On the basis of technology, molecular assay led the industry with a share, of 65%, in 2023, and it will continue to dominate in the future as well.

The diagnostics category dominated the transplant diagnostics market, with a share of 70%, in 2023, and it will continue like this in the future. This is credited to the increasing occurrence of ailments.

Furthermore, the diagnostic category is divided into pre-transplantation and post-transplantation diagnostic. Additionally, for transplant processes, all relative diagnostic tests will be done prior to the transplant to see the compatibility of the transplant for example blood profiling, histocompatibility testing, and communicable disease testing.

North America had the largest share, of 50%, in 2023, and it will continue like this in the future. This has a lot to do with the high acceptance rate of cutting-edge techniques and analytic tools, high healthcare spending, the obtainability of skilled experts, and the extensive use of soft tissue transplants, stem cell therapies, and tailored medications.

Furthermore, the growing count of organ replacements, the increasing consciousness of transplantation, the growing incidence of communicable ailments, and the rising elderly populace susceptible to chronic ailments are powering the industry.

There is an increasing number of organ transplants happening around the world, and this will power the demand for transplant diagnostic solutions. The trend will continue in the years to come as well.

Read More

North America Is Dominating Clinical Trial Biorepository & Archiving Solutions Industry

In 2023, the global clinical trial biorepository & archiving solutions market generated revenue of USD 3,985.2 million, which is expected to grow at a compound annual growth rate of 8.2% to reach USD 6,916.6 million by 2030.

To learn more about this report: https://bit.ly/3RQt6TM

This growth of the market can be credited to the rising count of companies offering an extensive variety of services and the growing trend of outsourcing storage and other cold-chain processes so that the essential resources can concentrate more on medicinal development.

Furthermore, storage and transport techs are constantly advancing, which, combined with the l regulatory needs on bio-storage and the present trends in this space, can enormously help in saving money, time, and effort.

The clinical trial biorepository & archiving solutions industry is rising quickly because of the improvement in the obtainability of less expensive devices to compile data, for streamline reporting, using software that provides the functionality of a combined laboratory information management system made to aid in managing laboratory samples and information.

In 2023, the North American region dominated the clinical trial biorepository & archiving solutions market with the largest share of 55%, and the region is also estimated to continue with the dominance in the future. This is mainly because of the rising number of clinical trials, the presence of global market leaders, and the usage of progressive techs in the region. Furthermore, the presence of a huge count of service providers, CROs, and biopharmaceutical businesses enhances the market growth potential.

Hence, this growth of the market can be credited to the rising count of companies offering an extensive variety of services and the growing trend of the outsourcing of storage and other cold-chain processes, so that the essential resources can concentrate more on medicinal development.

Read More

Unveiling the Growth Potential: Exploring the Humic Acid Market

In the world of agriculture and horticulture, humic acid has emerged as a key player, fostering soil fitness and crop productiveness. This natural compound, derived from decayed natural matter, has won significant interest in recent years. Let's delve into the dynamic landscape of the humic acid market, exploring its current traits, packages, and the factors using its boom.

The humic acid market revenue will stand at an estimated USD 757.0 million in 2023. Moreover, from 2024 to 2030, it will grow at a CAGR of 11.9% and reach USD 1,632.9 million by 2030.

Understanding Humic Acid:

A complex mixture of organic materials resulting from the decomposition of plant and animal material, humic acid is a fundamental constituent of humus. Humic acid, widely known for its capacity to increase soil structure, fertility, and nutrient absorption, is becoming an essential ingredient in today's agricultural production.

Market Dynamics:

The humic acid market is experiencing robust growth, driven by a confluence of factors. One 

of the primary catalysts is the increasing awareness among farmers and agriculturists about the benefits of using humic acid in soil management. As sustainable agriculture practices gain traction, humic acid's organic nature, and soil-friendly attributes position it as a preferred choice for fostering crop growth.

Moreover, the escalating demand for meal production to satisfy the wishes of a developing worldwide populace has intensified the point of interest in optimizing agricultural practices. Humic acid's function in enhancing nutrient availability, water retention, and normal soil fitness aligns with the search for higher crop yields and sustainable farming methods.

Key Applications:

The packages of humic acid extend beyond traditional agriculture, encompassing a variety of sectors. In addition to soil amendments, humic acid unearths work in animal feed dietary supplements, foliar sprays, and environmental remediation. Its versatility has contributed to its large adoption, making it a multi-faceted answer for diverse challenges in agriculture and beyond.

Global Market Trends:

The humic acid marketplace isn't always confined to a specific area, as its demand has been progressively developing on a worldwide scale. North America, Europe, Asia-Pacific, and Latin America are witnessing improved humic acid usage, propelled by agricultural intensification and the need for sustainable practices.

Innovation and Research:

As the humic acid market evolves, ongoing research and innovation play a pivotal role. Researchers and manufacturers are exploring novel extraction methods, improving formulation techniques, and expanding the range of applications. These advancements aim to unlock the full potential of humic acid, ensuring its efficacy in diverse settings and addressing specific agricultural challenges.

The humic acid market stands as a testament to the evolving landscape of agriculture. As the arena grapples with the need for sustainable and efficient farming practices, humic acid emerges as a precious best friend in improving soil health and crop productiveness. With ongoing studies, technological improvements, and a growing worldwide recognition, the humic acid market is poised for continued expansion, contributing to the transformation of present-day agriculture.

Read More

North America Is Dominating Stem Cell Therapy Industry

The global stem cell therapy market was 306.1 million USD in 2023 and is estimated to grow at an annual rate of 16.9% from 2024 until 2030 with a forecasted value of USD 910.8 million. This growth of the market can be credited to the growing occurrence of traumatic wounds, orthopedic conditions, neurological illnesses, and autoimmune diseases, such as multiple sclerosis, stroke, lupus, Parkinson’s disease, COPD, and amyotrophic lateral sclerosis (ALS).

In 2023, allogeneic stem cell therapy had the largest share, 60%, and the same is also projected to advance at a CAGR of 17.0% during the projection period. This can be credited to the surge in the count of clinical trials for the growth of such treatments. The major benefit of an allogeneic transplant is that the graft does not have any polluting tumor cells. The graft also comprises immunocompetent cells derived from a donor, which might add an immune graft-versus-malignancy effect.

Furthermore, numerous studies on stem cell transplants have displayed potential results. For example, a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, in January 2023 says that an investigational allogeneic T-cell treatment, which simultaneously aims 6 different viruses, has shown advanced safety and efficacy in phase II clinical trial on patients who had gone through stem cell transplantation to cure cancer and certain blood-linked illnesses.

In 2023, on the basis of the application segment, the musculoskeletal disorders category produced the highest revenue. This can be credited to the growing occurrence of musculoskeletal sicknesses, such as osteoarthritis, carpal tunnel syndrome, lower back injuries, and muscle strains. As per the WHO, around 1.71 billion individuals have a musculoskeletal condition worldwide.

In 2023, North America accounted for the largest share of 55 %; this is expected to rise significantly at a compound annual growth rate between 2024 and 30. The funding for the development of stem cell therapies in this area has been credited with that. For example, in September 2022, Forge Biologics Inc., a contract development and manufacturing organization focused on gene therapy announced that it had raised USD 90 million in a Series C funding round with an additional undisclosed strategic investor cooled by Drive Capital and Aisling Capital together with another unknown strategic investor.

Read More

Surging Aging Population Boosts Medical Exoskeleton Industry

The medical exoskeleton market was USD 485.8 million in 2023, which will increase to USD 6,336.8 million, powering at a 44.8% CAGR, by 2030.

This growth is because of the surging number of individuals with physical disabilities, the rising number of orthopedic surgeries, and the mounting elderly populace. For example, as per the WHO, 1 in 6 individuals globally, or around 1.3 billion individuals, experience substantial disability.

Furthermore, the mounting number of serious injuries, strokes, and road accidents is assisting the industry expansion. Around 1.3 million individuals die every year due to road traffic accidents, according to the WHO. Therefore, the rising acceptance of medical exoskeletons to heal injuries is further boosting this expansion.

In 2023, the hardware category, based on component, led the industry, with a 60% share, and it will propel at a 45.0% CAGR, during this decade. This can be because exoskeletons are produced with different pieces of hardware like sensors, actuators, control systems, and powered systems.

The powered category is the larger type, primarily owing to the new developments in them. For example, with investment from the National Institutes of Health, Stanford University has created an exoskeleton that rapidly adapts to users’ motions while they walk naturally.

Moreover, the passive category is a significant contributor to the industry. Passive exoskeletons are mainly accepted in low-income and developing nations, particularly by those who can’t buy the powered ones.

North America led the industry in 2023, with a 55% share, and it will further advance at a significant rate, in the years to come. This will be because of the mounting aging populace, rising government support for exoskeletons, and the high occurrence of neurological illnesses.

APAC is the fastest-growing region. This can be primarily ascribed to the increasing funding in healthcare, the growing patient pool requiring mobility support and rehabilitation, and the latest product approvals.

With the surge in the elderly populace across the globe, the medical exoskeleton industry will continue to progress in the years to come.

Read More

CNAPP Market Will Reach USD 33,723.4 Million By 2030

In 2023, the market for Cloud-Native Application Protection Platform was USD 9,460.8 million and is expected to reach USD 33,723.4 million by 2030 at a compound annual growth rate of 20.0%.

The use of cloud servers, coupled with an increasing number of cyberattacks in various sectors, is largely too accountable for this development.

The platform category, based on offering, leads the industry. This can be because of the rising need for comprehensive native systems working in various applications to streamline detecting, acting, or monitoring for cloud workloads and environments; monitor for exposures; and quicken risk hunting.  

Applications to reduce response times, assist DevSecOPS crews, enhance the main security problems, allow risk hunting and address runtime threats are a further helping hand in increasing demand for CNAPP.

The public category, based on cloud type, will dominate the industry during this decade. This is attributed to its low price because there is no necessity to buy any software or hardware. The hardware, servers, software, or other associated infrastructure are possessed by third-party providers and directed by the essential authority.   

Moreover, this type is frequently employed for web-based applications, email, testing, and storage; development environments, and online offices. 

In 2023, the BFSI category, based on vertical, was the largest contributor to the CNAPP market, with a share of 35%, and it will remain the largest throughout this decade. This can be attributed to the fact that cloud computing, coupled with its native models as well as architecture infuse the agility of BFSI business. 

Furthermore, cloud computing enables innovation, decreases prices for enterprises, and offers a competitive advantage, and it is an important part of the digital uprising, changing the BFSI sector. 

The large enterprises category, based on enterprise size, leads the industry in 2023. The occurrence of cyber fraud as well as data theft post-pandemic has augmented. This has resulted in the surging acceptance of CNAPP by these enterprises to improve safety procedures and battle future threats or attacks.  

North America was the largest contributor to the industry, with USD 5.2 billion in 2023, and it will propel at a high rate in the years to come. This can be because of the existence of key companies and stringent rules as well as the mounting inventions in this field. 

Whereas, APAC is likely to have a decent share of the industry in the years to come. This will be mainly because of the presence of nations such as India, China, South Korea, and Japan, which are the major technology innovators. 

It is because of the surging count of cyberattacks across different sectors, the CNAPP industry will continue to progress in the years to come. 

Read More